An extended comparison done with the GEPIA online tool [41] confirmed that WDFY2 expression is significantly reduced in different cancer types (acronyms in green font) with the only exception of Acute Myeloid Leukemia (LAML, red font) where an opposite effect is visible (Supplementary Figure S4F). This evidence concerns the gene WDFY2 and cancer.